| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0001 | 1 |